Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

被引:515
作者
Naito, A
Azuma, S
Tanaka, S
Miyazaki, T
Takaki, S
Takatsu, K
Nakao, K
Nakamura, K
Katsuki, M
Yamamoto, T
Inoue, J
机构
[1] Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan
[2] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 1130033, Japan
[3] Univ Tokyo, Inst Med Sci, Div DNA Biol & Embryo Engn, Dept Immunol,Ctr Expt Med,Minato Ku, Tokyo 1088639, Japan
关键词
D O I
10.1046/j.1365-2443.1999.00265.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: TRAF6, a member of the tumour necrosis factor receptor-associated factor family, was first identified as a transducer of CD40 and interleukin-l receptor (IL-1R) signals based on the interaction of TRAF6 with the cytoplasmic tail of CD40 and with the IL-1R associated kinase in vitro. However, the functions of TRAF6 in vivo remain unidentified. Results: We show that TRAF6(-/-) mice exhibit severe osteopetrosis and are defective in osteoclast formation. In vitro culture experiments revealed that osteoclast precursor cells derived from TRAF6(-/-) mice are unable to differentiate to functional osteoclasts in response to osteoclast differentiation factor (ODF), In bone marrow of TRAF6(-/-) mice, the number of sIgM(+)B220(+) immature B cells is markedly reduced while the ratio of proB to preB cells is not affected. In contrast, development of thymocytes is not affected. Furthermore, TRAF6(-/-) mice are defective in lymph node organogenesis and IL-1 signalling in thymocytes. Conclusions: The results identify TRAF6 as an essential component of ODF signalling pathway, and also show that TRAF6 plays pivotal roles in immune and inflammatory systems in vivo.
引用
收藏
页码:353 / 362
页数:10
相关论文
共 43 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[3]   Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adaptor proteins that regulates life and death [J].
Arch, RH ;
Gedrich, RW ;
Thompson, CB .
GENES & DEVELOPMENT, 1998, 12 (18) :2821-2830
[4]   TARF6 is a signal transducer for interleukin-1 [J].
Cao, ZD ;
Xiong, J ;
Takeuchi, M ;
Kurama, T ;
Goeddel, DV .
NATURE, 1996, 383 (6599) :443-446
[5]   INVOLVEMENT OF CRAF1, A RELATIVE OF TRAF, IN CD40 SIGNALING [J].
CHENG, GH ;
CLEARY, AM ;
YE, ZS ;
HONG, DI ;
LEDERMAN, S ;
BALTIMORE, D .
SCIENCE, 1995, 267 (5203) :1494-1498
[6]   Characterization of the intracellular domain of receptor activator of NF-κB (RANK) -: Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase [J].
Darnay, BG ;
Haridas, V ;
Ni, J ;
Moore, PA ;
Aggarwal, BB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20551-20555
[7]   Requirement for NF-κB in osteoclast and B-cell development [J].
Franzoso, G ;
Carlson, L ;
Xing, LP ;
Poljak, L ;
Shores, EW ;
Brown, KD ;
Leonardi, A ;
Tran, T ;
Boyce, BF ;
Siebenlist, U .
GENES & DEVELOPMENT, 1997, 11 (24) :3482-3496
[8]   The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-κB, a member of the TNFR superfamily [J].
Galibert, L ;
Tometsko, ME ;
Anderson, DM ;
Cosman, D ;
Dougall, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) :34120-34127
[9]  
GODFREY DI, 1993, J IMMUNOL, V150, P4244
[10]   C-FOS - A KEY REGULATOR OF OSTEOCLAST-MACROPHAGE LINEAGE DETERMINATION AND BONE REMODELING [J].
GRIGORIADIS, AE ;
WANG, ZQ ;
CECCHINI, MG ;
HOFSTETTER, W ;
FELIX, R ;
FLEISCH, HA ;
WAGNER, EF .
SCIENCE, 1994, 266 (5184) :443-448